• Barrow, L., Brown, R.D., Murray, A., Sze, D.M., Pope, B., Gibson, J., Hart, D. & Joshua, D. (2003) CMRF44+ dendritic cells from peripheral blood stem cell harvests of patients with myeloma as potential cellular vectors for idiotype vaccination. Leukemia and Lymphoma, 44, 21172122.
  • Bendandi, M., Gocke, C.D., Kobrin, C.B., Benko, F.A., Sternas, L.A. & Pennington, R. (1999) Complete molecular remissions induced by patient-specific vaccinations plus granulocyte-monocyte colony stimulating factor against lymphoma. Nature Medicine, 5, 11711177.
  • Brown, R.D., Pope, B., Murray, A., Esdale, W., Sze, D.M., Gibson, J., Ho, P.J., Hart, D. & Joshua, D (2001) Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10. Blood, 98, 29922998.
  • DeBenedette, M.A., Shahinian, A., Mak, T.W. & Watts, T.H. (1997) Costimulation of CD28− T lymphocytes by 4-1BB ligand. Journal of Immunology, 158, 551559.
  • Dhodapkar, M.V., Geller, M.D., Chang, D.H., Shimizu, K., Fujii, S., Dhodapkar, K.M. & Krasovsky, J. (2003) A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. Journal of Experimental Medicine, 997, 16671676.
  • Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Cancer, 36, 842854.
  • Egner, W., Andreeesen, R. & Hart, D.N. (1993) Allostimulatory cells in fresh human blood: heterogeneity in antigen-presenting cell populations. Transplantation, 56, 945950.
  • Emtage, P.C., Clarke, D., Gonzalo-Dagonzo, R. & Junghans, R.P. (2003) Generating potent Th1/Tc1 T cell adoptive immunotherapy doses using human IL-12: harnessing the immunomodulatory potential of IL-12 without the in vivo-associated toxicity. Journal of Immunotherapy, 26, 97106.
  • Fearnley, D.B., McLellan, A.D., Mannering, S.I., Hock, B.D. & Hart, D.N. (1997) Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy. Blood, 89, 37083716.
  • Hart, D.N.J. (1997) Dendritic cells: unique leukocyte populations which control the primary immune response. Blood, 90, 32453287.
  • Joshua, D.E., Brown, G. & MacLennan, I.C. (1979) Immune suppression in BALB/c mice bearing the plasmacytoma TEPC-183: evidence for normal lymphocyte but defective for normal lymphocyte but defective macrophage function. International Journal of Cancer, 23, 663672.
  • Kleijmeer, M.J., Morkowski, S., Griffith, J.M., Rudensky, A.Y. & Geuze, H.J. (1997) Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. Journal of Cell Biology, 139, 639649.
  • Laderach, D., Wesa, A. & Galy, A. (2003) 4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12. Cellular Immunology, 226, 3744.
  • Maecker, B., Anderson, K.S., von Bergwelt-Baildon, M.S., Weller, E., Vonderheide, R.H., Richardson, P., Schlossman, R.L., Menezes, I.A., Xia, Z., Munshi, N., Anderson, K., Nadler, L. & Schultze, J.L. (2003) Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma. British Journal of Haematology, 121, 842848.
  • Nijman, H.W., Kleijmeer, M.J., Ossevoort, M.A., Oorschot, V.M.J., Vierboom, M.P.M., van de Keur, M., Kenemans, P., Kast, W.M., Geuze, H.J. & Melief, C.M.J. (1995) Antigen capture and MHC class II compartments of freshly isolated and cultured human blood dendritic cells. Journal of Experimental Medicine, 182, 163174.
  • Pfeiffer, S., Gooding, R.P., Apperley, J.F., Goldschmidt, H. & Samson, D. (1997) Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors. British Journal of Haematology, 98, 973982.
  • Raje, N., Gong, J., Chauhan, D., Teoh, G., Avigan, D., Wu, Z., Chen, D., Treon, S.P., Webb, I.J., Kufe, D.W. & Anderson, K.C. (1999) Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequences. Blood, 93, 14871495.
  • Ratta, M., Fagnoni, F., Curti, A., Vescovini, R., Sansoni, P., Oliviero, B., Fogli, M., Ferri, E., Della Cuna, G.R., Tura, S., Baccarani, M. & Lemoli, R.M. (2002) Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood, 100, 230237.
  • Robertson, J.D., Nagesh, K., Dougal, M., Anderson, H., Mutton, K., Zambon, M. & Scarffe, J.H. (2000) Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae in patients with multiple myeloma. British Journal of Cancer, 82, 12611265.
  • Ruffini, P.A., Neelapu, S.S., Kwak, L. & Biragyn, A. (2002) Idiotypic vaccination of B cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. Haematologica, 87, 9891001.
  • Vuckovic, S., Kim, M., Khalil, D., Turtle, C.J., Crosbie, G.V., Williams, N., Brown, L., Williams, K., Kelly, C., Stravos, P., Rodwell, R., Hill, G.R., Wright, S., Taylor, K., Gill, D., Marlton, P., Bradstock, K. & Hart, D.N. (2003) Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression. Blood, 101, 23142317.
  • Xie, J., Wang, Y., Freeman III, M.E., Barlogie, B. & Yi, Q. (2003) Beta 2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells. Blood, 101, 40054012.
  • Zinneman, H.H. & Hall, W.H. (1954) Recurrent pneumonia in multiple myeloma and some observations on immunologic response. Annals of Internal Medicine, 41, 11521170.